Haleon PLC
ISIN: GB00BMX86B70 | Ticker: HLN | LEI: 549300PSB3WWEODCUP19
Country: United Kingdom
We are a world-leading consumer health companywith a clear purpose to deliver better everyday health with humanity.
Our leading brands are built on science, innovation and human understanding and are trusted by millions of consumers globally. Haleon has a strong portfolio of brands and is well positioned to play a vital role for people all around the world, in a sector that is growing and more relevant than ever.
The definition of consumer healthcare varies across competitors and industry data sources. We define it as consisting of Oral Health, VMS and Over-the-Counter (OTC). Within OTC, Haleon's portfolio comprises of Pain, Respiratory, Digestive and Other.
2022
Served areaWorldwide
Headcount24,622
HeadquartersBuilding 5, First Floor, The Heights, KT13 0NY Weybridge – United Kingdom
| Line item in (gbp) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | N/A | 34,451,000,000.00 | 34,815,000,000.00 |
| Noncurrent Assets | N/A | N/A | 29,200,000,000.00 | 30,756,000,000.00 |
| Property Plant And Equipment | N/A | N/A | 1,563,000,000.00 | 1,757,000,000.00 |
| Deferred Tax Assets | N/A | N/A | 312,000,000.00 | 220,000,000.00 |
| Noncurrent Recognised Assets Defined Benefit Plan | N/A | N/A | 11,000,000.00 | 25,000,000.00 |
| Noncurrent Derivative Financial Assets | N/A | N/A | 12,000,000.00 | 44,000,000.00 |
| Other Noncurrent Assets | N/A | N/A | 8,000,000.00 | 132,000,000.00 |
| Current Assets | N/A | N/A | 5,251,000,000.00 | 4,059,000,000.00 |
| Inventories | N/A | N/A | 951,000,000.00 | 1,348,000,000.00 |
| Trade And Other Current Receivables | N/A | N/A | 2,207,000,000.00 | 1,881,000,000.00 |
| Current Tax Assets Current | N/A | N/A | 166,000,000.00 | 96,000,000.00 |
| Cash and cash equivalents | N/A | 333,000,000.00 | 414,000,000.00 | 684,000,000.00 |
| Current Derivative Financial Assets | N/A | N/A | 5,000,000.00 | 50,000,000.00 |
| Equity | 27,412,000,000.00 | 26,223,000,000.00 | 26,480,000,000.00 | 16,457,000,000.00 |
| Issued Capital | N/A | N/A | 1,000,000.00 | 92,000,000.00 |
| Retained Earnings | N/A | N/A | 37,538,000,000.00 | 26,730,000,000.00 |
| Share Premium | N/A | N/A | 0.00 | 0.00 |
| Other Reserves | N/A | N/A | -11,632,000,000.00 | -11,537,000,000.00 |
| Equity Attributable To Owners Of Parent | N/A | N/A | 26,355,000,000.00 | 16,331,000,000.00 |
| Noncontrolling Interests | N/A | N/A | 125,000,000.00 | 126,000,000.00 |
| Liabilities | N/A | N/A | 7,971,000,000.00 | 18,358,000,000.00 |
| Noncurrent Liabilities | N/A | N/A | 3,733,000,000.00 | 13,988,000,000.00 |
| Noncurrent Provisions | N/A | N/A | 27,000,000.00 | 26,000,000.00 |
| Deferred Tax Liabilities | N/A | N/A | 3,357,000,000.00 | 3,601,000,000.00 |
| Noncurrent Recognised Liabilities Defined Benefit Plan | N/A | N/A | 253,000,000.00 | 161,000,000.00 |
| Noncurrent Derivative Financial Liabilities | N/A | N/A | 1,000,000.00 | 175,000,000.00 |
| Other Noncurrent Liabilities | N/A | N/A | 8,000,000.00 | 22,000,000.00 |
| Longterm Borrowings | N/A | N/A | 87,000,000.00 | 10,003,000,000.00 |
| Current Liabilities | N/A | N/A | 4,238,000,000.00 | 4,370,000,000.00 |
| Current Provisions | N/A | N/A | 112,000,000.00 | 71,000,000.00 |
| Trade And Other Current Payables | N/A | N/A | 3,002,000,000.00 | 3,621,000,000.00 |
| Current Tax Liabilities Current | N/A | N/A | 202,000,000.00 | 210,000,000.00 |
| Current Derivative Financial Liabilities | N/A | N/A | 18,000,000.00 | 31,000,000.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | N/A | 79,000,000.00 | 437,000,000.00 |
| Line item in (gbp) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 9,892,000,000.00 | 9,545,000,000.00 | 10,858,000,000.00 |
| Profit Loss From Operating Activities | 1,598,000,000.00 | 1,638,000,000.00 | 1,825,000,000.00 |
| Finance Income | 20,000,000.00 | 17,000,000.00 | 51,000,000.00 |
| Finance Costs | 27,000,000.00 | 19,000,000.00 | 258,000,000.00 |
| Profit Loss Before Tax | 1,591,000,000.00 | 1,636,000,000.00 | 1,618,000,000.00 |
| Income Tax Expense Continuing Operations | 410,000,000.00 | 197,000,000.00 | 499,000,000.00 |
| Profit (loss) | 1,181,000,000.00 | 1,439,000,000.00 | 1,119,000,000.00 |
| Profit Loss Attributable To Owners Of Parent | 1,145,000,000.00 | 1,390,000,000.00 | 1,060,000,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 36,000,000.00 | 49,000,000.00 | 59,000,000.00 |
| Line item in (gbp) | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|
| Profit (loss) | 1,181,000,000.00 | 1,439,000,000.00 | 1,119,000,000.00 |
| Adjustments For Income Tax Expense | 410,000,000.00 | 197,000,000.00 | 499,000,000.00 |
| Adjustments For Decrease Increase In Inventories | 130,000,000.00 | -17,000,000.00 | -292,000,000.00 |
| Adjustments For Increase Decrease In Trade Account Payable | 140,000,000.00 | 41,000,000.00 | 387,000,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 88,000,000.00 | 1,000,000.00 | 143,000,000.00 |
| Adjustments For Provisions | -27,000,000.00 | -36,000,000.00 | -43,000,000.00 |
| Adjustments For Fair Value Gains Losses | 91,000,000.00 | 0.00 | 0.00 |
| Other Adjustments For Noncash Items | 100,000,000.00 | -22,000,000.00 | 24,000,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 209,000,000.00 | 31,000,000.00 | 30,000,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 554,000,000.00 | 310,000,000.00 | 324,000,000.00 |
| Cash Flows From Used In Operating Activities | 1,407,000,000.00 | 1,356,000,000.00 | 2,063,000,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 221,000,000.00 | 0.00 | 0.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | -20,000,000.00 | 0.00 | 0.00 |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | 6,000,000.00 | 12,000,000.00 | 0.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | 222,000,000.00 | 228,000,000.00 | 304,000,000.00 |
| Proceeds From Sales Of Intangible Assets Classified As Investing Activities | 924,000,000.00 | 137,000,000.00 | 36,000,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | 96,000,000.00 | 70,000,000.00 | 24,000,000.00 |
| Interest Received Classified As Investing Activities | 19,000,000.00 | 16,000,000.00 | 19,000,000.00 |
| Cash Flows From Used In Investing Activities | 1,030,000,000.00 | -33,000,000.00 | -8,784,000,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 38,000,000.00 | 8,000,000.00 | 11,004,000,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 10,000,000.00 | 0.00 | 1,518,000,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 44,000,000.00 | 38,000,000.00 | 45,000,000.00 |
| Interest Paid Classified As Financing Activities | 19,000,000.00 | 15,000,000.00 | 163,000,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | 0.00 | -12,000,000.00 | 345,000,000.00 |
| Cash Flows From Used In Financing Activities | -2,437,000,000.00 | -1,236,000,000.00 | 6,911,000,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -6,000,000.00 | -4,000,000.00 | 15,000,000.00 |
| Cash and cash equivalents | 333,000,000.00 | 414,000,000.00 | 684,000,000.00 |
Please note that some sums might not add up.
GB00BMX86B70
LEI549300PSB3WWEODCUP19
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryFTSE 100
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.